Portfolio Companies News
April 29, 2016WILSON THERAPEUTICS ANNOUNCES INITI...
Apr 29, 2016 Read the full press release at https://www.wilsontherapeutics.com/ipo For more information contact Jonas Hansson, CEO Tel: +46 (0)70 944 18 77 Email: email@example.com Anders Martin-Löf, CFO Tel: +46 (0)70 683 79 77 Email: firstname.lastname@example.org Abo... read more
April 21, 2016Interim Report January-March 2016
Unless otherwise stated in this report, all data refers to the Group. Figures in parentheses relate to the corresponding period in 2015. Orexo reports positive cash flow for the quarter First quarter 2016 Total net revenues MSEK 151.0 (149.0). Zubsolv® net revenue MSEK 98.4 (94.5). ... read more
April 21, 2016Nexstim Plc announces the change of...
Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company aiming to improve rehabilitation for stroke patients with the use of non-invasive brain stimulation, announces that Janne Huhtala has stepped down as CEO of Nexstim to explore new opportunities. Martin Jamieson, Nexstim’s Chairman, w... read more
April 20, 2016SAVE THE DATE - NORDIC NANOVECTOR C...
Oslo, Norway, 20 April 2016 Nordic Nanovector ASA (OSE: NANO) is pleased to announce that it will host a Capital Markets Day onTuesday 31 May 2016 in Oslo. The program will begin at 08:30 CEST, followed by lunch. A formal invitation, including the full programme and registration details, will be ... read more
April 18, 2016Onxeo Final Data from Mechanistic L...
Full results presented at AACR Annual Meeting 2016 Support continued evaluation of Livatag® in ongoing Phase III ReLive Trial Paris (France), Copenhagen (Denmark) – Onxeo S.A. (Euronext Paris, Nasdaq Copenhagen: ONXEO), an innovative company specializing in the development of orphan oncology... read more